Long Covid: doctors find ‘antibody signature’ for patients most at risk
Low levels of certain antibodies found to be more common in those who go on to develop long Covid
Doctors have discovered an “antibody signature” that can help identify patients most at risk of developing long Covid, a condition where debilitating symptoms of the disease can persist for many months.
Researchers at University hospital Zurich analysed blood from Covid patients and found that low levels of certain antibodies were more common in those who developed long Covid than in patients who swiftly recovered.
Leave a Reply